Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huperzine A Sustained-Release Tablets in Mild to Moderate Alzheimer's Disease
CTR20140253Phase 3Active
- Sponsor
- Shandong Green Leaf Natural Medicine Research and Development
- Start
- Apr 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Huperzine A in Alzheimer's disease (AD), sponsored by Shandong Green Leaf Natural Medicine Research and Development. Started Apr 2014; status: active.
02
Drugs
Huperzine A
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on CTR20140253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140253.